About
Wound & Burn Care
Areas of Focus
Categories
Small Molecule PharmaceuticalMiddle East
Clinical Trials (14)
View allTotal Trials
14
As Lead Sponsor
14
As Collaborator
0
Total Enrollment
1,290
By Phase
PHASE3: 4PHASE2: 6PHASE1/PHASE2: 1
By Status
COMPLETED: 8RECRUITING: 2NOT_YET_RECRUITING: 1UNKNOWN: 1TERMINATED: 1APPROVED_FOR_MARKETING: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06568627Lead Sponsor
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
PHASE3Recruiting
216 participants
Started: Apr 30, 2025 · Completed: Mar 31, 2027
NCT06690177Lead Sponsor
Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers
PHASE2Not yet recruiting
45 participants
Started: Apr 30, 2025 · Completed: Sep 30, 2028
NCT05157763Lead Sponsor
A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
PHASE1/PHASE2Recruiting
32 participants
Started: Jun 30, 2021 · Completed: Jun 30, 2022
NCT04817228Lead Sponsor
A Study to Evaluate the Clinical Performance, Safety and Pharmacology Effect of EscharEx in Patients With Lower Leg Ulcers
PHASE2Completed
12 participants
Started: Apr 21, 2021 · Completed: May 20, 2022
NCT03588130Lead Sponsor
A Study to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg Ulcers
PHASE2Completed
120 participants
Started: Dec 2, 2019 · Completed: Mar 23, 2022
Locations (1)
Headquarters
Yavne, Israel
Map
Loading map...